Starling Oncology, Inc. Retained Earnings
Starling Oncology, Inc. (DFPH) had Retained Earnings of -$283.70 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-06
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$283.70M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$273.91M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$271.42M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$263.91M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2026-06-30 | -$283.70M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | -$273.91M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | -$271.42M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | -$263.91M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | -$247.41M 10-Q · filed 2025-08-13 | |
| 2025-03-31 | -$230.40M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | -$210.81M 10-K · filed 2026-03-12 | |
| 2024-09-30 | -$197.63M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | -$181.52M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | -$166.04M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | -$146.15M 10-K · filed 2025-03-26 | |
| 2023-09-30 | -$127.40M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | -$109.98M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | -$93.08M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | -$63.08M 10-K · filed 2024-03-28 | |
| 2022-09-30 | -$52.08M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | -$49.40M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | -$43.95M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | -$63.23M 10-K · filed 2023-03-16 | |
| 2021-09-30 | -$24.90M 10-Q/A · filed 2021-12-14 | |
| 2021-06-30 | -$24.47M 10-Q/A · filed 2021-12-14 | -$8.78M 10-Q · filed 2021-08-16 |
| 2021-03-31 | -$18.35M 10-Q/A · filed 2021-12-14 | -$2.66M 10-Q · filed 2021-05-28 |
| 2020-12-31 | -$52.31M 10-K · filed 2022-03-11 | -$443.45K 10-K · filed 2021-03-30 |
| 2020-09-30 | -$21.51M 10-K/A · filed 2021-12-14 | -$300.78K 10-Q · filed 2020-11-13 |
| 2020-06-30 | -$19.09M 10-K/A · filed 2021-12-14 | -$163.12K 10-Q · filed 2020-08-13 |
| 2020-03-31 | -$16.47M 10-K/A · filed 2021-12-14 | -$47.39K 10-Q · filed 2020-05-08 |
| 2020-03-13 | -$16.04M 10-K/A · filed 2021-12-14 | |
| 2019-12-31 | -$2.30K 10-K/A · filed 2021-12-14 |